Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
European Journal of Clinical Microbiology & Infectious Diseases
Published in: European Journal of Clinical Microbiology & Infectious Diseases 10/2010

01-10-2010 | Brief Report

First outbreak of PVL-positive nonmultiresistant MRSA in a neonatal ICU in Australia: comparison of MALDI-TOF and SNP-plus-binary gene typing

Authors: S. Schlebusch, G. R. Price, S. Hinds, C. Nourse, J. M. Schooneveldt, M. H. Tilse, H. G. Liley, T. Wallis, F. Bowling, D. Venter, G. R. Nimmo

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 10/2010

Login to get access

Abstract

The purpose of this brief report is to describe the first outbreak of a community-associated nonmultiresistant and PVL-positive MRSA strain (CC30) in a neonatal intensive care unit in Australia. The utility of matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry (MALDI-TOF-MS) for microbial typing is compared with single nucleotide polymorphism (SNP) plus binary gene analysis. The composite correlation index analysis of the MALDI-TOF-MS data demonstrated the similar inter-strain relatedness found with the SNP-plus-binary gene typing used to confirm the outbreak. The evolving spread of MRSA emphasizes the importance of surveillance, infection control vigilance and the ongoing investigation of rapid typing methods for MRSA.
Literature
1.
Isaacs D, Fraser S, Hogg G, Li HY (2004) Staphylococcus aureus infections in Australasian neonatal nurseries. Arch Dis Child 89(4):F331–F335
2.
O’Brien FG, Pearman JW, Gracey M, Riley TV, Grubb WB (1999) Community strain of methicillin-resistant Staphylococcus aureus involved in a hospital outbreak. J Clin Microbiol 37(9):2858–2862PubMed
3.
Huygens F, Inman-Bamber J, Nimmo GR, Munckhof W, Schooneveldt J, Harrison B, McMahon JA, Giffard PM (2006) Staphylococcus aureus genotyping using novel real-time PCR formats. J Clin Microbiol 44(10):3712–3719CrossRefPubMed
4.
Sauer S, Freiwald A, Maier T, Kube M, Reinhardt R, Kostrzewa M, Geider K (2008) Classification and identification of bacteria by mass spectrometry and computational analysis. PLoS ONE 3(7):e2843CrossRefPubMed
5.
Arnold RJ, Reilly JP (1998) Fingerprint matching of E. coli strains with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry of whole cells using a modified correlation approach. Rapid Commun Mass Spectrom 12(10):630–636CrossRefPubMed
6.
Taneike I, Otsuka T, Dohmae S, Saito K, Ozaki K, Takano M, Higuchi W, Takano T, Yamamoto T (2006) Molecular nature of methicillin-resistant Staphylococcus aureus derived from explosive nosocomial outbreaks of the 1980s in Japan. FEBS Lett 580(9):2323–2334CrossRefPubMed
7.
Centers for Disease Control and Prevention (1999) Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus—Minnesota and North Dakota, 1997–1999. JAMA 282(12):1123–1125
8.
Vandenesch F, Naimi T, Enright MC, Lina G, Nimmo GR, Heffernan H, Liassine N, Bes M, Greenland T, Reverdy ME, Etienne J (2003) Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 9(8):978–984PubMed
9.
Zetola N, Francis JS, Nuermberger EL, Bishai WR (2005) Community-acquired methicillin-resistant Staphylococcus aureus: an emerging threat. Lancet Infect Dis 5(5):275–286CrossRefPubMed
10.
Andersen BM, Bergh K, Steinbakk M, Syversen G, Magnaes B, Dalen H, Bruun JN (1999) A Norwegian nosocomial outbreak of methicillin-resistant Staphylococcus aureus resistant to fusidic acid and susceptible to other antistaphylococcal agents. J Hosp Infect 41(2):123–132CrossRefPubMed
11.
Saiman L, O’Keefe M, Graham PL 3rd, Wu F, Said-Salim B, Kreiswirth B, LaSala A, Schlievert PM, Della-Latta P (2003) Hospital transmission of community-acquired methicillin-resistant Staphylococcus aureus among postpartum women. Clin Infect Dis 37(10):1313–1319CrossRefPubMed
12.
O’Brien FG, Lim TT, Chong FN, Coombs GW, Enright MC, Robinson DA, Monk A, Said-Salim B, Kreiswirth BN, Grubb WB (2004) Diversity among community isolates of methicillin-resistant Staphylococcus aureus in Australia. J Clin Microbiol 42(7):3185–3190CrossRefPubMed
13.
Lina G, Piemont Y, Godail-Gamot F, Bes M, Peter MO, Gauduchon V, Vandenesch F, Etienne J (1999) Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 29(5):1128–1132CrossRefPubMed
14.
Nourse C, Starr M, Munckhof W (2007) Community-acquired methicillin-resistant Staphylococcus aureus causes severe disseminated infection and deep venous thrombosis in children: literature review and recommendations for management. J Paediatr Child Health 43(10):656–661CrossRefPubMed
15.
David MD, Kearns AM, Gossain S, Ganner M, Holmes A (2006) Community-associated methicillin-resistant Staphylococcus aureus: nosocomial transmission in a neonatal unit. J Hosp Infect 64(3):244–250CrossRefPubMed
16.
Nguyen DM, Bancroft E, Mascola L, Guevara R, Yasuda L (2007) Risk factors for neonatal methicillin-resistant Staphylococcus aureus infection in a well-infant nursery. Infect Control Hosp Epidemiol 28(4):406–411CrossRefPubMed
17.
Saunders A, Panaro L, McGeer A, Rosenthal A, White D, Willey BM, Gravel D, Bontovics E, Yaffe B, Katz K (2007) A nosocomial outbreak of community-associated methicillin-resistant Staphylococcus aureus among healthy newborns and postpartum mothers. Can J Infect Dis Med Microbiol 18(2):128–132PubMed
18.
Sax H, Posfay-Barbe K, Harbarth S, Francois P, Touveneau S, Pessoa-Silva CL, Schrenzel J, Dharan S, Gervaix A, Pittet D (2006) Control of a cluster of community-associated, methicillin-resistant Staphylococcus aureus in neonatology. J Hosp Infect 63(1):93–100CrossRefPubMed
19.
Gould IM, Girvan EK, Browning RA, Mackenzie FM, Edwards GF (2009) Report of a hospital neonatal unit outbreak of community-associated methicillin-resistant Staphylococcus aureus. Epidemiol Infect 137:1242–1248
20.
Bratu S, Eramo A, Kopec R, Coughlin E, Ghitan M, Yost R, Chapnick EK, Landman D, Quale J (2005) Community-associated methicillin-resistant Staphylococcus aureus in hospital nursery and maternity units. Emerg Infect Dis 11(6):808–813PubMed
21.
Regev-Yochay G, Rubinstein E, Barzilai A, Carmeli Y, Kuint J, Etienne J, Blech M, Smollen G, Maayan-Metzger A, Leavitt A, Rahav G, Keller N (2005) Methicillin-resistant Staphylococcus aureus in neonatal intensive care unit. Emerg Infect Dis 11(3):453–456PubMed
22.
Zingg W, Posfay-Barbe KM, Pittet D (2008) Healthcare-associated infections in neonates. Curr Opin Infect Dis 21(3):228–234CrossRefPubMed
23.
Behari P, Englund J, Alcasid G, Garcia-Houchins S, Weber SG (2004) Transmission of methicillin-resistant Staphylococcus aureus to preterm infants through breast milk. Infect Control Hosp Epidemiol 25(9):778–780CrossRefPubMed
24.
CDC (2006) Community-associated methicillin-resistant Staphylococcus aureus infection among healthy newborns—Chicago and Los Angeles County, 2004. MMWR 55(12):329–332
25.
Denniston S, Riordan FA (2006) Staphylococcus aureus bacteraemia in children and neonates: a 10 year retrospective review. J Infect 53(6):387–393CrossRefPubMed
26.
Fortunov RM, Hulten KG, Hammerman WA, Mason EO Jr, Kaplan SL (2007) Evaluation and treatment of community-acquired Staphylococcus aureus infections in term and late-preterm previously healthy neonates. Pediatrics 120(5):937–945CrossRefPubMed
27.
Robinson DA, Kearns AM, Holmes A, Morrison D, Grundmann H, Edwards G, O’Brien FG, Tenover FC, McDougal LK, Monk AB, Enright MC (2005) Re-emergence of early pandemic Staphylococcus aureus as a community-acquired methicillin-resistant clone. Lancet 365(9466):1256–1258CrossRefPubMed
28.
Berglund C, Soderquist B (2008) The origin of a methicillin-resistant Staphylococcus aureus isolate at a neonatal ward in Sweden-possible horizontal transfer of a staphylococcal cassette chromosome mec between methicillin-resistant Staphylococcus haemolyticus and Staphylococcus aureus. Clin Microbiol Infect 14(11):1048–1056CrossRefPubMed
29.
Jackson KA, Edwards-Jones V, Sutton CW, Fox AJ (2005) Optimisation of intact cell MALDI method for fingerprinting of methicillin-resistant Staphylococcus aureus. J Microbiol Meth 62(3):273–284CrossRef
30.
Walker J, Fox AJ, Edwards-Jones V, Gordon DB (2002) Intact cell mass spectrometry (ICMS) used to type methicillin-resistant Staphylococcus aureus: media effects and inter-laboratory reproducibility. J Microbiol Meth 48(2–3):117–126CrossRef
31.
Bernardo K, Pakulat N, Macht M, Krut O, Seifert H, Fleer S, Hunger F, Kronke M (2002) Identification and discrimination of Staphylococcus aureus strains using matrix-assisted laser desorption/ionization-time of flight mass spectrometry. Proteomics 2(6):747–753CrossRefPubMed
32.
Laing IA, Gibb AP, McCallum A (2009) Controlling an outbreak of MRSA in the neonatal unit: a steep learning curve. Arch Dis Child 94(4):F307–F310
33.
Lepelletier D, Corvec S, Caillon J, Reynaud A, Roze JC, Gras-Leguen C (2009) Eradication of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit: which measures for which success? Am J Infect Control 37(3):195–200CrossRefPubMed
34.
Coombs GW, Van Gessel H, Pearson JC, Godsell MR, O’Brien FG, Christiansen KJ (2007) Controlling a multicenter outbreak involving the New York/Japan methicillin-resistant Staphylococcus aureus clone. Infect Control Hosp Epidemiol 28(7):845–852CrossRefPubMed
Metadata
Title
First outbreak of PVL-positive nonmultiresistant MRSA in a neonatal ICU in Australia: comparison of MALDI-TOF and SNP-plus-binary gene typing
Authors
S. Schlebusch
G. R. Price
S. Hinds
C. Nourse
J. M. Schooneveldt
M. H. Tilse
H. G. Liley
T. Wallis
F. Bowling
D. Venter
G. R. Nimmo
Publication date
01-10-2010
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 10/2010
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-010-0995-y

Other articles of this Issue 10/2010

European Journal of Clinical Microbiology & Infectious Diseases 10/2010 Go to the issue

Article

Revisiting the effect of referral bias on the clinical spectrum of infective endocarditis in adults

Article

Impact of antibiotic therapy on systemic cytokine expression in pneumococcal pneumonia

Review

Diagnostic tests for tuberculous pleural effusion

Article

Antimicrobial resistance in colonizing group B Streptococci before the implementation of a Swedish intrapartum antibiotic prophylaxis program

Brief Report

The molecular characteristics of cefepime-susceptible Escherichia coli and Klebsiella spp. isolates with a positive β-lactamase screening test result but negative confirmation

Article

Comparison of daptomycin Etest MICs on Mueller Hinton, IsoSensitest and brain heart infusion agars from Europe against 20 Staphylococcus aureus isolates
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits